Our approach has been validated in cells, animals, and in the clinic.
We’re answering questions across the entire development process.
From identifying new targets to optimizing compounds for toxicity or efficacy – our platform evaluates preclinical R&D as a whole. Our holistic view enables us to share data and insights across the drug development pipeline, leading to informed and expansive insights.
Currently we’ve built in over 14 different algorithms into the platform and we’re constantly adding in more.